Mostrar el registro sencillo del ítem

dc.contributor.authorLiñán-Barroso, Juan Manuel
dc.contributor.authorHernández Rodríguez, Juan Carlos
dc.contributor.authorRuiz Villaverde, Ricardo
dc.contributor.authorGalán Gutiérrez, Manuel
dc.contributor.authorNavarro-Triviño, Francisco
dc.contributor.authorDomínguez-Cruz, Javier
dc.contributor.authorArmario Hita, José Carlos 
dc.contributor.authorPereyra-Rodriguez, José-Juan
dc.contributor.otherCirugíaes_ES
dc.contributor.otherMedicinaes_ES
dc.date.accessioned2025-11-18T08:36:31Z
dc.date.available2025-11-18T08:36:31Z
dc.date.issued2025-03
dc.identifier.issn1651-2057
dc.identifier.urihttp://hdl.handle.net/10498/37955
dc.description.abstractA consensus study of experts was conducted to establish a definition of the concept of super-responders (SR) in atopic dermatitis (AD). The study employed a Delphi methodology based on 2 rounds to define the concept of SR in AD, exploring the opinions of expert dermatologists in AD from across Spain regarding a series of statements developed after a systematic review. Consensus was predefined as an agreement of ≥ 80% among all respondents. In the first round, 4 statements reached consensus. In the second round, 2 additional statements reached consensus. To illustrate these definitions, a set of practical cases was provided, and the level of agreement among experts was evaluated. According to the agreed statements, time is important when defining the achievable response as SR. The concept of SR should associate a rapid response (before week 16), include both symptom variables, such as the Eczema Area and Severity Index and Investigators Global Assessment (IGA) and patient-reported outcomes, including pruritus or the Patient-Oriented Eczema Measure. This concept should be associated with complete or nearly complete clearance of lesions (IGA 0–1), and with sustained responses over time (at week 52). Mild flares (IGA ≤2) may occur without varying according to the patient’s age.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMJS Publishinges_ES
dc.rightsAttribution-NonCommercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.sourceActa dermato-venereologica - 2025, Vol. 105 pp. 1-9es_ES
dc.subjectatopic dermatitises_ES
dc.subjectbiological agentses_ES
dc.subjectDelphi consensuses_ES
dc.subjectJanus kinase inhibitorses_ES
dc.titleDefinition of the Concept of Super-responders in Atopic Dermatitis: A Spanish Delphi Consensuses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.2340/ACTADV.V105.42240
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Attribution-NonCommercial 4.0 Internacional